<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>ISRG Stock Down More than 13% in 3 Months: How to Play the Stock? — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?</h2>
    <div class="badge">2025-09-15T13:01:00+00:00</div>
    <ul>
      <li>ISRG has raised its full-year 2025 procedure growth guidance to 15.5-17% from 13-16% previously.</li>
<li>The company anticipates gross margin to contract 200-300 bps to 66-67% for full-year 2025, which includes 100 bps from tariffs alone.</li>
<li>Per a Grand View Research report, the global surgical robots market size is expected to witness a CAGR of almost 9.4% from 2025 to 2030.</li>
<li>Image Source: Zacks Investment Research Challenges Gross Margin Contraction: Adjusted gross profit was $1.66 billion, up 17.8% year over year.</li>
<li>During the first quarter, the gross margin was 66.4%, down approximately 120 bps from the prior-year quarter’s figure.</li>
<li>However, as a percentage of revenues, the gross margin was 67.9%, down approximately 200 bps from the prior-year quarter’s figure.</li>
<li>Recurring revenues accounted for 85% of total sales in the first half of 2025, highlighting the significance of instruments and accessories (I&amp;A).</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=ISRG Stock Down More than 13% in 3 Months: How to Play the Stock?\n• ISRG has raised its full-year 2025 procedure growth guidance to 15.5-17% from 13-16% previously.\n• The company anticipates gross margin to contract 200-300 bps to 66-67% for full-year 2025, which includes 100 bps from tariffs alone.\n• Per a Grand View Research report, the global surgical robots market size is expected to witness a CAGR of almost 9.4% from 2025 to 2030.\n• Image Source: Zacks Investment Research Challenges Gross Margin Contraction: Adjusted gross profit was $1.66 billion, up 17.8% year over year.\n• During the first quarter, the gross margin was 66.4%, down approximately 120 bps from the prior-year quarter’s figure.\n• However, as a percentage of revenues, the gross margin was 67.9%, down approximately 200 bps from the prior-year quarter’s figure.\n• Recurring revenues accounted for 85% of total sales in the first half of 2025, highlighting the significance of instruments and accessories (I&amp;A)." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/isrg-stock-down-more-13-130100672.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>